国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2012年
3期
375-377
,共3页
银杏达莫%脑复康%痴呆%血管性
銀杏達莫%腦複康%癡呆%血管性
은행체막%뇌복강%치태%혈관성
Ginkgo dipyridamoleinjection%Piracetar%Dementia%Vascular
目的 研究银杏达莫注射液联合脑复康治疗血管性痴呆的效果.方法 将81例血管性痴呆患者随机分为治疗组和对照组.对照组给予脑复康片0.2 g口服治疗,每次2片,每天3次,连续服用2个月；治疗组在此基础上给予银杏达莫注射液30 ml加入生理盐水250 ml中静脉滴注,15d一个疗程,连续应用3个疗程.记录比较两组患者治疗前后MMSE、HDS及ADL评分结果.结果 两组患者接受治疗后评分结果均明显好于治疗前(P＜ 0.01)且治疗组评分结果显著好于对照组(P＜ 0.01).结论 银杏达莫注射液联合脑复康治疗血管性痴呆有显著临床效果,值得推广应用.
目的 研究銀杏達莫註射液聯閤腦複康治療血管性癡呆的效果.方法 將81例血管性癡呆患者隨機分為治療組和對照組.對照組給予腦複康片0.2 g口服治療,每次2片,每天3次,連續服用2箇月；治療組在此基礎上給予銀杏達莫註射液30 ml加入生理鹽水250 ml中靜脈滴註,15d一箇療程,連續應用3箇療程.記錄比較兩組患者治療前後MMSE、HDS及ADL評分結果.結果 兩組患者接受治療後評分結果均明顯好于治療前(P＜ 0.01)且治療組評分結果顯著好于對照組(P＜ 0.01).結論 銀杏達莫註射液聯閤腦複康治療血管性癡呆有顯著臨床效果,值得推廣應用.
목적 연구은행체막주사액연합뇌복강치료혈관성치태적효과.방법 장81례혈관성치태환자수궤분위치료조화대조조.대조조급여뇌복강편0.2 g구복치료,매차2편,매천3차,련속복용2개월；치료조재차기출상급여은행체막주사액30 ml가입생리염수250 ml중정맥적주,15d일개료정,련속응용3개료정.기록비교량조환자치료전후MMSE、HDS급ADL평분결과.결과 량조환자접수치료후평분결과균명현호우치료전(P＜ 0.01)차치료조평분결과현저호우대조조(P＜ 0.01).결론 은행체막주사액연합뇌복강치료혈관성치태유현저림상효과,치득추엄응용.
Objective To explore the efficacy of ginkgo dipyridamole injection combined with piracetar in the treatment of vascular dementia.Methods 81 patients were randomly assigned to receive oral piracetar of 200mg alone,thrice daily for two months ( control group ),or oral piracetar combined with ginkgo dipyridamole injection of 30ml for 3 courses ( study group,15 days for each course ).The scores for MMSE,HDS,and ADL were compared with the baselines in the two groups after treatment.Results After treatment,the scores of MMSE and HDS were significantly higher than that in the observation group ( P ＜ 0.01 ) and the ADL score was significantly lower ( P ＜ 0.01 ).Conclusions Ginkgo dipyridamole injection combined with piracetar for vascular dementia is efficacious and is worth popularizing.
